Open Access
Table 1
Characteristics of the CytoSorb300 and HA 330 cartridges.
| Type of cartridges | CytoSorb 300 (Cytosorbents Europe GmbH) | HA 330(Jafron Biomedical Co., Ltd. China) |
|---|---|---|
| Adsorbent | Proprietary and patented cross-linked divinylbenzene polymer | A styrene-divinylbenzene copolymer |
| Cartridge volume (mL) | 300 | 330 |
| Adsorption spectrum | Small and mid-size hydrophobic molecules up to a size of approximately 60 kDa | With an approximate pore size distribution corresponding to a molecular weight range of 10–60 kDa |
| Maximum pressure limit | 760 mm Hg | 750 mm Hg |
| Maximum procedure duration | 24 h | 6 h |
| Anticoagulation | Heparin or citrate | Heparin or citrate |
| Priming fluid, procedure, and duration: | CytoSorb does not require priming/coating with heparin. Flushing with 2000 mL of 0.9% NaCl solution. | Flushing with 2500 ml of 0.9% NaCl solution + 12500ME heparin. |
| Priming takes approximately 5 min. | The flushing takes about 50 min. |
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.